International Drug Detection Firm Identa Corporation Continues Expansion - Adds Six Countries To World-Wide Marketing Network

JERUSALEM, December 13 /PRNewswire-FirstCall/ -- IDenta Corp. announced today that it has added four new firms to its network of international representatives. Companies in Indonesia, Holland, France and Turkey have recently signed agreements to represent IDenta's growing line of proprietary, on-site drug detection products. IDTA now has representatives in 26 countries including 23 companies in the U.S., and 4 companies in Great Britain.

IDenta's newly signed representatives are:

1. PT Kurongkor UTAMA, www.kurongkor.com, in Indonesia, with extensive contacts inside the country's law enforcement agencies. Kurongkor expects to begin product demonstrations before Indonesia's law enforcement agencies starting in early 2006.

2. Isodon Holding S.R.L, will represent IDenta in Holland, Luxemburg, and Belgium.

3. IBtec, www.ibtecnet.com, will begin marketing in France where IDenta's products have recently been tested on a large scale by numerous public agencies. IDenta said it expects to receive a very large order from France in the near future.

4. Retired General (Israeli Police), Shlomo Gal (IDenta's advisor) was in November in Turkey, invitation from a local company with extensive contacts to the Turkish Police. General Gal presented IDenta's products before the Head of the Turkish Police Forensic Department in Ankara, Turkey. The Turkish Police are now testing the company's products.

About IDenta

IDenta Corporation is the leading developer of proprietary on-site drug detection kits used by governments and security forces around the world. Information concerning IDenta's business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at www.identa.biz and www.drugsdetector.com.

IDenta proudly supports "D.A.M.M.A.D.D.", Dads and Mad Moms Against Drug Dealers, (www.dammadd.org)

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally contact:

Yaacov Shoham, IDenta Corp., CEO Tel: +972-52-6554487, +972-8-9716874 Fax: +972-8-9716875 fpi@drugsdetector.com

CONTACT: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487,+972-8-9716874, Fax: +972-8-9716875, fpi@drugsdetector.com